Clinical trial Recruiting at 1 site Interventional Ages 18 to 45

Evaluating a new method for Implantable Collamer Lens implantation to treat high myopia

Official title: Prospective, Multicenter,Randomized Clinical Investigation of A Viscoelastic-free Method for Implantable Collamer Lens (ICL) Implantation to Treat High Myopia: A Pilot Study

Run by Wenzhou Medical University · NCT03059043 · Data updated 2026-11-12

This study is testing a new way to implant a special lens for people with severe nearsightedness to see if it’s safer and works better than the usual method.

More Myopia trials

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment60 (estimated)
SponsorWenzhou Medical University
Academic / other
Locations5 sites (Guangzhou, Guangdong and 4 other locations)
StatusRecruiting
StartedNovember 16, 2018
Main results expectedJune 22, 2028
Study endsJune 22, 2028
Registry record updatedAugust 18, 2026
Trial IDNCT03059043 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with stable high myopia who meet specific ocular health criteria and have a best spectacle-corrected visual acuity of 20/40 or better.

Probably not a fit

Patients with preexisting ocular diseases, systemic conditions, or those who are pregnant or planning to become pregnant may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study assesses the safety and efficacy of a viscoelastic-free method for Implantable Collamer Lens (ICL) implantation in patients with high myopia. Participants will have one eye treated using the new method and the other eye using the standard viscoelastic-assisted method, allowing for a direct comparison of outcomes. Post-operative data will be collected at multiple follow-up intervals to evaluate the clinical effectiveness and safety of both techniques. The goal is to determine if the new method can reduce complications associated with viscoelastic agents during surgery.

Why it matters

Potential benefit: If successful, this method could lead to safer and more effective ICL implantation for patients with high myopia.

How similar studies have gone: While the standard method has been widely used, this viscoelastic-free approach is novel and has not been extensively tested in previous studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Documented stable refraction for at least 1 year(within 0.5D)
* Best spectacle-corrected visual acuity (BCVA) of 20/40 or better
* Clear central cornea
* -0.5D to -18.0D of myopic refractive error
* Normal anterior chamber depth at least 2.8 mm to endothelium
* Endothelial cell density (ECD) more than 2000 cell/mm2
* Pupil diameter smaller than 7.0 mm under mesopic condition
* Discontinued 3 weeks for hard contact lens and 1 week for soft contact lens wear

Exclusion Criteria:

* Preexisting ocular diseases or conditions other than myopia, evidence of progressive or acute ocular disease
* Evidence of connective tissue disease or other systemic diseases that may confound the results of the study;
* Narrow angle of anterior chamber
* Pregnant, lactating, or planning to become pregnant during the course of the trial

Where it's running

  • The Eye Hispital of Wenzhou Medical University
    Wenzhou, Zhejiang, China
    Recruiting
  • Guangdong General Hospital
    Guangzhou, Guangdong, China
    Not yet recruiting
  • Hunan Provincial People's Hospital
    Changsha, Hunan, China
    Not yet recruiting
  • Peking Union Medical College Hospital
    Beijing, China
    Not yet recruiting
  • Shanghai Ninth People's Hospital
    Shanghai, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.